ALK-negative anaplastic large cell lymphoma with CNS involvement needs more than just brentuximab vedotin
Crossref DOI link: https://doi.org/10.1007/s00277-016-2746-3
Published Online: 2016-07-27
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abid, Muhammad Bilal https://orcid.org/0000-0002-1128-0445
Wang, Shi
Loi, Hoi Yin
Poon, L. M.
License valid from 2016-07-27
